Abstract
5-Fluorouracil is used as an antineoplastic agent in solid tumors. The study was conducted to analyze the effect of EDDA on synthesis of 5-fluorouracil with 99mTc. The 99mTc-5-flurouracil was formulated using stannous agent, and EDDA. This complex was stable for 4 h, with post labeling efficiency of 92 %. The distribution study in animal model showed that after 30 min 35 ± 8 % of injected dose cross the blood brain barrier and excreted through kidney with no sign of toxicity. It was concluded that the addition of EDDA modified the labeling side in 5-fluorouracil for 99mTc, which localized in brain and hence can be used further for brain imaging study.
Similar content being viewed by others
References
Moritz FK, Adam Z, Jesse VJ, Cristina LZ, Paul JK, Erik M, Ken P, Ruimin H, Carl C, Frezghi H, Robert S, Cameron WB, Ingo KM, Eric CH, Sanjiv SG (2012) A brain tumor molecular imaging strategy using a new triple-modality MRI-Photoacoustic-Raman nanoparticle. Nat Med 18(5):829–834
Committee on State of the Science of Nuclear Medicine, National Research Council (2007) Advancing nuclear medicine through innovation. The National Academies Press, ISBN: 0-309-11068-8
Filippi L, Santoni R, Manni C, Danieli R, Floris R, Schillaci O (2005) Imaging primary brain tumors by single-photon emission computerized tomography (SPECT) with Technetium-99m Sestamibi (MIBI) and Tetrofosmin. Curr Med Imaging Rev 1(1):61–66
Garcia V, Garcia JM, Pena C, Silva J, Dominguez G, Hurtado A, Alonso I, Rodriguez R, Provencio M, Bonilla F (2006) Thymidylate synthase messenger RNA expression in plasma from patients with colon cancer: prognostic potential. Clin Cancer Res 12(7):2095–2100
Okarvi SM, Jammaz AL (2010) Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors. Nucl Med Biol 37(3):277–288
Faheem AR, Bokhari TH, Roohi S, Mushtaq A, Sohaib M (2013) 99mTc-Daunorubicin a potential brain imaging and theranostic agent: synthesis, quality control, characterization, biodistribution and scintigraphy. Nucl Med Biol 40:148–152
Hina S, Roohi S, Rajoka MI, Haque A, Bokhari TH, Sohaib M (2015) Preparation, quality control and biological characterization of 99mTc-vincristine. J Radioanal Nucl Chem 304(2):553–561
Ume KD, Irfan UK, Javed M, Ali M, Waqar SH, Sohail M, Jamil A (2013) Development of 99mTc-5-fluorouracil as a potential tumor diagnostic agent. Pak J Pharm Sci 26(2):333–337
Liu S (2004) The role of coordination chemistry in the development of target specific radiopharmaceuticals. J Chem Soc 33:445–461
Rashid R, Javed M, Fayyaz A, Asima S, Sohail M, Misbah M, Shahid R, Saqib R (2013) Preparation of 99mTc-labeled methotrexate by a direct labeling technique as a potential diagnostic agent for breast cancer and preliminary clinical results. Hell J Nucl Med 16(1):33–37
Terence JB, Benjamin HB, Brian PM, Elson LS, Mary FH, Michael KC, Joseph H, Clifford RJ (1999) Comparative study of 99mTc-ECD and 99mTc-HMPAO for peri-ictal SPECT: qualitative and quantitative analysis. J Neurol Neurosurg Psychiatry 66:331–339
Kung HF (2001) Development of 99mTc labeled tropanes: TRODAT-1, as a dopamine transporter imaging agent. Nucl Med Biol 28(5):505–508
Johannsen B, Pietzsch HJ (2002) Development of technetium-99m-based CNS receptor ligands: have there been any advances? Eur J Nucl Med Mol Imaging 29(2):263–275
Ralf S, Vadim BG, Andrew R, Jean P, Soucy Esther S, Björn W, Carmen W (2013) Design of brain imaging agents for positron emission tomography: do large bioconjugates provide an opportunity for in vivo brain imaging? Future Med Chem. doi:10.4155/fmc.13.128
Gilman AG, Ral TW, Nies AS, Taylor P (1990) The pharmacological basis of therapeutics. Pergamon Press, New York
Rockville (2010) United States Pharmacopeia Convention, (2): 2874–2875
Diasio RB, Harris BE (1989) Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet 6(4):215–237
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ahmed, N., Saeed, A.M., Fatima, S. et al. Synthesis, development and preclinical study of EDDA based 99mTc-5-fluorouracil for brain imaging. J Radioanal Nucl Chem 309, 805–811 (2016). https://doi.org/10.1007/s10967-015-4690-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-015-4690-4